GC376_COA_25475_MedChemExpress

Mechanisms:
Pathways:GPCR/G protein; Target:CCR5 Pathways:Microbiology; Target:CCR5
g y Biological Activity: Maraviroc (UK-427857; Selzentry; Celsentri) is a Selective CCR5 antagonist; displays potent antiHIV-1 activity. Maraviroc (UK-427857; Selzentry; Celsentri) prevents the interaction of HIV-1 gp120 and CCR5 (IC50 = 6.4 nM), inhibiting HIV-1 entry. Maraviroc also inhibits CCL3 (MIP-1α) binding to CCR5.
References: [1]. Dorr et al (2005) Maraviroc (UK-427,857), a potent, orally bioavailable, and selective smallmolecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob.Agents Chemother. 49 4721. [2]. [ ] Romero-Sánchez MC, Machmach K, Gonzalez-Serna A, Genebat M, Pulido I, García-García M, Alvarez-Ríos AI, Ferrando-Martinez S, Ruiz-Mateos E, Leal M.Effect of maraviroc on HIV-disease progression-related biomarkers.Antimicrob Agents Chemother. 2012 Sep 4. [3]. Lu Y, Hendrix CW, Bumpus NN.Cytochrome P450 3A5 Plays a Prominent Role in the Oxidative Metabolism of the Anti-HIV Drug Maraviroc.Drug Metab Dispos. 2012 Aug 24. [4]. Willig JH, Wilkins SA, Tamhane A, Nevin CR, Mugavero MJ, Raper JL, Napolitano LA, Saag MS.Maraviroc Observational Study: The Impact of Expanded Resistance Testing and Clinical Conside...

Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Sep.-21-2017Print Date:Sep.-21-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :GC376Catalog No. :HY-100721CAS No. :1416992-39-61.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:GC–376; GC376Formula:C21H30N3NaO8SMolecular Weight:507.53CAS No. :1416992-39-64. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

对 应 药材 的 相 关性 进 行 快 速 比较 分 析 。
关键词 ： 清肝注射液； 茵陈； 气相 色 质谱联用； 光谱相关色 谱一 谱
中图分 类号 ：２ ４ ２ Ｒ ８ ．
ห้องสมุดไป่ตู้
文献标识 码 ： Ａ
文章 编号 ：０ ８０ ０ （ ０ ８ １ —７ ４ ２ １０ －８ ５ ２ ０ ） １２ ５ － ０
时珍国医国药 ２０ ０ ８年第 １ ９卷第 １ 期 １
ＬＳ ＩＨ ＮＭ ＤＣＮ Ｎ Ａ Ｅ Ｉ Ｅ ＩＡＲ Ｓ Ａ Ｃ ０Ｖ Ｌ１ Ｏ １ ＩＨＺ Ｅ Ｅ ＩＩＥＡ ＤＭ Ｔ ＲＡＭ ＤＣ ＥＥ Ｒ Ｈ２ ８ Ｏ ．９Ｎ ．１ ０
气 相 色谱 一质谱 联 用 和光 谱相 关 色谱 法 用 于清肝 注射 液及 茵 陈药 材 中挥 发性 成 分 的相关 分 析
ＧＡ ｉｙ ｎ，ＧＵＯ Ｆ ｎ － ｕ ，ＹＩＬ ｎ－ｈ ｏ，ＬＡＮＧ Ｙｉｚ ｎ Ｏ Ｈａ — ａ ａ ｇ ｑｉ ｕ ｚａ Ｉ －ｅ ｇ
（ ｏ ｅｅ ｆＣ ｅ ｓ ｙａ ｄＣ ｅ ｃｌ ｎ ｉ ｅ ｎ Ｃ ｎｒｌ ｏｔ ｎｖｒｔ，Ｃ ａ ｇｈ ， １０ ３ Ｃ ｉａ Ｃ ｌｇ ｈｍｉｒ ｎ ｈｍｉ ｇｎ ｒ ｇ， ｅｔ ｕｈＵ ｉ ｓｙ ｈ ｎ ｓａ ４ ０ ８ ， ｈｎ ） ｌ ｏ ｔ ａＥ ｅｉ ａＳ ｅｉ
Ａ ａｙ ｉ ｏ ｏａｉ ｏ ｏ ｅ ｔ ｉ ｎ ｇ ｎＩｊｃｉｎ ａ ｄＨｅｂ ｒ ｍｉａ ｃｐ ｒ ｅｂ ｎ ｌｓ ｆＶ ｌｔｅＣ ｍｐ ｎ ｎｓ ｎ Ｑｉｇ ａ ｎｅｔ ｎ ｒ ａＡ ｔ ｓ ｅＳ ｏ ａｉ ｙ ｓ ｌ ｏ ｅ ｉ ａ
ＧＣ —Ｍ Ｓ ａ ｐ ｃ ｒ ｌＣｏ ｒ ｌ ｔｖ ｎｄ Ｓ ｅ ｔ ａ ｒ ｅ ａ ｉ ｅ Ｃｈｒ ｍａ ｏ ｒ ｐ ｙ ｏ ｔｇ ａ ｈ

专利名称：丹酚酸A冻干粉针用于制备抑制脑组织神经元损伤或死亡药物的用途
专利类型：发明专利
发明人：杨小玲,罗恒真,魏宇清,李志勇,曾发林,刘鹏
申请号：CN201210488012.4
申请日：20121120
公开号：CN103120649A
公开日：
20130529
专利内容由知识产权出版社提供
摘要：本发明涉及一种丹酚酸A冻干粉针用于制备抑制脑组织神经元损伤或死亡药物的用途，其中，所述丹酚酸A冻干粉针的重量配比为：丹酚酸A20g～60g，填充剂20g～60g，抗氧剂为制成总量的0.02％～0.1％。

申请人：陆文萍
地址：100097 北京市海淀区南淀厂南路39号玫瑰御园4栋1单元301室
国籍：CN
更多信息请下载全文后查看。